Annual Total Debt
$3.79 M
-$1.81 M-32.30%
30 June 2024
Summary:
Renovaro Biosciences annual total debt is currently $3.79 million, with the most recent change of -$1.81 million (-32.30%) on 30 June 2024. During the last 3 years, it has fallen by -$3.52 million (-48.20%). RENB annual total debt is now -50.07% below its all-time high of $7.58 million, reached on 01 June 2020.RENB Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$3.82 M
+$34.40 K+0.91%
30 September 2024
Summary:
Renovaro Biosciences quarterly total debt is currently $3.82 million, with the most recent change of +$34.40 thousand (+0.91%) on 30 September 2024. Over the past year, it has dropped by -$3.57 million (-48.30%). RENB quarterly total debt is now -55.43% below its all-time high of $8.57 million, reached on 31 March 2024.RENB Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RENB Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -32.3% | -48.3% |
| 3 y3 years | -48.2% | -47.8% |
| 5 y5 years | +100.0% | +97.9% |
RENB Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -48.2% | at low | -55.4% | +0.9% |
| 5 y | 5 years | -50.1% | -55.4% | +97.9% | |
| alltime | all time | -50.1% | -55.4% |
Renovaro Biosciences Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.82 M(+0.9%) |
| June 2024 | $3.79 M(-32.3%) | $3.79 M(-55.8%) |
| Mar 2024 | - | $8.57 M(+16.0%) |
| Dec 2023 | - | $7.39 M(+60.8%) |
| Sept 2023 | - | $4.60 M(-17.8%) |
| June 2023 | $5.59 M(-20.3%) | - |
| June 2023 | - | $5.59 M(-20.5%) |
| Mar 2023 | - | $7.04 M(+0.4%) |
| Dec 2022 | - | $7.01 M(+0.4%) |
| Sept 2022 | - | $6.99 M(-0.4%) |
| June 2022 | $7.02 M(-4.0%) | $7.02 M(-4.1%) |
| Mar 2022 | - | $7.32 M(+0.0%) |
| Dec 2021 | - | $7.32 M(+0.0%) |
| Sept 2021 | - | $7.31 M(+0.1%) |
| June 2021 | $7.31 M(-3.6%) | $7.31 M(+0.1%) |
| Mar 2021 | - | $7.31 M(-3.9%) |
| Dec 2020 | - | $7.60 M(+0.1%) |
| Sept 2020 | - | $7.59 M(+0.1%) |
| June 2020 | $7.58 M(>+9900.0%) | $7.58 M(+0.1%) |
| Mar 2020 | - | $7.57 M(+292.2%) |
| Dec 2019 | - | $1.93 M(-3.1%) |
| Sept 2019 | - | $1.99 M(>+9900.0%) |
| June 2019 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2019 | - | $0.00(0.0%) |
| Dec 2018 | - | $0.00(0.0%) |
| Sept 2018 | - | $0.00(0.0%) |
| June 2018 | $0.00 | $0.00(0.0%) |
| Mar 2018 | - | $0.00(-100.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | - | $209.30 K(-57.8%) |
| Sept 2017 | - | $496.00 K(-76.3%) |
| June 2017 | $2.09 M(+1930.9%) | $2.09 M(+374.8%) |
| Mar 2017 | - | $440.10 K(+6.6%) |
| Dec 2016 | - | $412.80 K(-5.3%) |
| Sept 2016 | - | $436.10 K(+323.8%) |
| June 2016 | $102.90 K(+2.3%) | $102.90 K(+0.2%) |
| Mar 2016 | - | $102.70 K(+1.3%) |
| Dec 2015 | - | $101.40 K(+0.2%) |
| Sept 2015 | - | $101.20 K(+1.9%) |
| June 2015 | $100.60 K(+0.6%) | - |
| Mar 2015 | - | $99.30 K(-0.7%) |
| Dec 2014 | $100.00 K(+57.0%) | $100.00 K(-93.8%) |
| Sept 2014 | - | $1.61 M(-6.2%) |
| June 2014 | - | $1.72 M(+0.7%) |
| Mar 2014 | - | $1.71 M(+2103.1%) |
| Dec 2013 | - | $77.40 K(+5.0%) |
| Sept 2013 | - | $73.70 K(+14.8%) |
| June 2013 | - | $64.20 K(+0.8%) |
| Mar 2013 | $63.70 K(+134.2%) | $63.70 K(+16.5%) |
| Dec 2012 | - | $54.70 K(+507.8%) |
| Sept 2012 | - | $9000.00(+80.0%) |
| June 2012 | - | $5000.00(-81.6%) |
| Mar 2012 | $27.20 K(>+9900.0%) | $27.20 K(+444.0%) |
| Dec 2011 | $0.00(0.0%) | $5000.00(>+9900.0%) |
| Sept 2011 | - | $0.00(0.0%) |
| June 2011 | - | $0.00 |
| Mar 2011 | $0.00 | - |
FAQ
- What is Renovaro Biosciences annual total debt?
- What is the all time high annual total debt for Renovaro Biosciences?
- What is Renovaro Biosciences annual total debt year-on-year change?
- What is Renovaro Biosciences quarterly total debt?
- What is the all time high quarterly total debt for Renovaro Biosciences?
- What is Renovaro Biosciences quarterly total debt year-on-year change?
What is Renovaro Biosciences annual total debt?
The current annual total debt of RENB is $3.79 M
What is the all time high annual total debt for Renovaro Biosciences?
Renovaro Biosciences all-time high annual total debt is $7.58 M
What is Renovaro Biosciences annual total debt year-on-year change?
Over the past year, RENB annual total debt has changed by -$1.81 M (-32.30%)
What is Renovaro Biosciences quarterly total debt?
The current quarterly total debt of RENB is $3.82 M
What is the all time high quarterly total debt for Renovaro Biosciences?
Renovaro Biosciences all-time high quarterly total debt is $8.57 M
What is Renovaro Biosciences quarterly total debt year-on-year change?
Over the past year, RENB quarterly total debt has changed by -$3.57 M (-48.30%)